Ambys Medicines Overview
- Year Founded
-
2018
- Status
-
Acquired/Merged
- Employees
-
61
- Latest Deal Type
-
M&A
Ambys Medicines General Information
Description
Developer of regenerative medical therapies intended to cure serious liver diseases. The company's medical therapies help in restoring liver function, prevent the progression of liver disease, and treat the devastating complications of liver failure, enabling patients suffering from chronic liver diseases to get relief through cell therapy and regenerative therapeutics.
Contact Information
Website
www.ambys.comCorporate Office
- 131 Oyster Point Boulevard
- Suite 200
- South San Francisco, CA 94080
- United States
Corporate Office
- 131 Oyster Point Boulevard
- Suite 200
- South San Francisco, CA 94080
- United States
Ambys Medicines Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 23-Feb-2023 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A) | 21-Dec-2021 | Completed | Pre-Clinical Trials | |||
| 2. Early Stage VC | 08-Aug-2018 | $80M | $140M | Completed | Product Development | |
| 1. Early Stage VC (Series A) | 08-Aug-2018 | $60M | $60M | Completed | Product Development |
Ambys Medicines Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
Ambys Medicines Comparisons
Industry
Financing
Details
Ambys Medicines Competitors (29)
One of Ambys Medicines’s 29 competitors is GoLiver Therapeutics, a Venture Capital-Backed company based in Nantes, France.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| GoLiver Therapeutics | Venture Capital-Backed | Nantes, France | ||||
| Qihan Biotech | Venture Capital-Backed | Hangzhou, China | ||||
| Inovio Pharmaceuticals | Corporation | Plymouth Meeting, PA | ||||
| HepaTx | Venture Capital-Backed | Palo Alto, CA | ||||
| Tioga Pharmaceuticals | Formerly VC-backed | San Diego, CA |
Ambys Medicines Patents
Ambys Medicines Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2023086958-A1 | Methods of producing and using human hepatocytes and related compositions | Inactive | 12-Nov-2021 | ||
| WO-2022164807-A2 | Genetically modified hepatocyte populations | Inactive | 26-Jan-2021 | ||
| WO-2022164807-A3 | Genetically modified hepatocyte populations | Inactive | 26-Jan-2021 | ||
| WO-2022140261-A1 | Biliary delivery methods, compositions and kits for use therein | Inactive | 22-Dec-2020 | ||
| CA-3158153-A1 | Tropolone derivatives and tautomers thereof for iron regulation in animals | Pending | 16-Oct-2019 | C07D307/12 |
Ambys Medicines Signals
Ambys Medicines Former Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Alexandria Venture Investments | Venture Capital | Minority | ||
| Laurion Capital Management | Hedge Fund | Minority | ||
| Schroders Capital | Asset Manager | Minority | ||
| Smilegate Investment | Venture Capital | Minority | ||
| Takeda Ventures | Corporate Venture Capital | Minority |
Ambys Medicines FAQs
-
When was Ambys Medicines founded?
Ambys Medicines was founded in 2018.
-
Where is Ambys Medicines headquartered?
Ambys Medicines is headquartered in South San Francisco, CA.
-
What is the size of Ambys Medicines?
Ambys Medicines has 61 total employees.
-
What industry is Ambys Medicines in?
Ambys Medicines’s primary industry is Drug Discovery.
-
Is Ambys Medicines a private or public company?
Ambys Medicines is a Private company.
-
What is Ambys Medicines’s current revenue?
The current revenue for Ambys Medicines is .
-
How much funding has Ambys Medicines raised over time?
Ambys Medicines has raised $187M.
-
Who are Ambys Medicines’s investors?
Alexandria Venture Investments, Laurion Capital Management, Schroders Capital, Smilegate Investment, and Takeda Ventures are 5 of 6 investors who have invested in Ambys Medicines.
-
Who are Ambys Medicines’s competitors?
GoLiver Therapeutics, Qihan Biotech, Inovio Pharmaceuticals, HepaTx, and Tioga Pharmaceuticals are some of the 29 competitors of Ambys Medicines.
-
When was Ambys Medicines acquired?
Ambys Medicines was acquired on 23-Feb-2023.
-
Who acquired Ambys Medicines?
Ambys Medicines was acquired by Cytotheryx.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process